Qiang Yu

Profile

余强博士 (Dr.Qiang Yu)
盛世泰科生物医药技术有限公司总裁兼首席执行官
Co-Founder, President and Chief Executive Officer, CGeneTech(Suzhou, China) Co., Ltd.

余强博士毕业于北京大学并获化学学士学位,后赴美深造,就读于堪萨斯大学,获化学博士学位。他读博期间的研究还曾被诺贝尔奖获得者让-马里·莱恩引用在他在发表在【自然】上的文章中。博士毕业后从师当时的美国制药科学家协会会长,进行了两年的博士后研究工作,研究利用Caco-2细胞作为体外方法评估药物化合物的生物有效性,该研究成果如今在全球制药行业得到了广泛的运用。

余强博士2010年归国后创办了盛世泰科生物医药技术有限公司任总裁兼首席执行官至今。

Dr. Yu studied chemistry at Peking University and obtained his B.S. in 1999. He then went to USA to continue his study at University of Kansas and obtained his Ph.D. there. His doctoral work was cited in Nobel Laureate Dr. Jean-Marie Lehn’s Nature paper. As a post-doctoral fellow, he worked with the president of the American Association of Pharmaceutical Scientists from 2000 to 2002, focusing on the use of Caco-2 cell in vitro model to evaluate the bioactivity of candidate medicinal compounds. The methods he developed are now widely used in the pharmaceutical industry globally.

Dr. Yu returned to China in 2010 and founded his own biotech company CGeneTech as the President and Chief Executive Officer.
  • 电话

    +86 (0)512
  • 电子邮件

  • 地址


    Suzhou Dushu Lake Science and Education Innovation District
    Suzhou Industrial Park
    Suzhou
    P.R.China
    215123